US Stocks
/
Tvardi Therapeutics, Inc. Share Price
Tvardi Therapeutics, Inc. Share Price

Tvardi Therapeutics, Inc. Share Price

NASDAQ: TVRD
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Tvardi Therapeutics, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Tvardi Therapeutics, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Tvardi Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-2.46
Revenue (TTM)
$7.14M
Return On Equity (TTM)
-86.96%
Profit Margin
-255.21%
Debt to Equity
0.53
Quarterly Earnings Growth YoY
84.02%

Tvardi Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025
RevenueN/A$991000.00$2.56M$2.57M
Net Profit-$30.70M-$20.02M-$12.48M-$4.91M
Net Profit MarginN/A-2019.78%-488.11%-190.97%
Income ChangeN/A34.79%37.67%60.68%

Tvardi Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2021202220232024
Revenue$23.03M$41.87M$20.97M$7.14M
Net Profit-$88.44M-$85.47M-$118.51M-$70.87M
Net Profit Margin-384.06%-204.16%-565.21%-992.95%
Income ChangeN/A3.35%-38.65%40.20%

About Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc. operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases. It develops inhibitors of STAT3, a molecule implicated in the initiation and progression of cancer and fibrosis. Its pipeline includes TTI-101, a small-molecule inhibitor of signal transducers and activators of transcription; and TTI-109, a STAT3 inhibitor for clinical use, including tolerability, bioavailability, and potency. Tvardi Therapeutics, Inc. was incorporated in 2017 and is based in Sugar Land, Texas.

Tvardi Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %

TVRD Share Price FAQs

What is Tvardi Therapeutics, Inc. share price today?

chevron-up
Tvardi Therapeutics, Inc. share price today is $0.00 as on September 20, 2026 at 8:41 pm IST.

What is the 52 week high and 52 week low of Tvardi Therapeutics, Inc. stock?

chevron-up
52 week high/low data for Tvardi Therapeutics, Inc. is currently unavailable.

What is TVRD's net income for the last quarter?

chevron-up
TVRD's net income for the last quarter is -0.00B USD.

Can I buy TVRD shares in India?

chevron-up
Yes. You can buy TVRD in India by opening an international trading account.